Scarica l'app Stockscreener
95.15
0.82%
0.77
Dopo l'orario di chiusura:
96.12
0.97
+1.02%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$94.38
Aprire:
$94.5
Volume 24 ore:
109.25K
Relative Volume:
0.69
Capitalizzazione di mercato:
$2.15B
Reddito:
$213.03M
Utile/perdita netta:
$41.32M
Rapporto P/E:
51.99
EPS:
1.83
Flusso di cassa netto:
$33.49M
1 W Prestazione:
+2.06%
1M Prestazione:
+13.70%
6M Prestazione:
-1.90%
1 anno Prestazione:
+14.90%
Intervallo 1D:
$94.42
$96.12
Intervallo di 1 settimana:
$90.93
$96.12
Portata 52W:
$71.42
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Nome
Lemaitre Vascular Inc
Settore
Industria
Telefono
781-221-2266
Indirizzo
63 SECOND AVENUE, BURLINGTON, MA
Confronta LMAT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
95.15 | 2.14B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
482.35 | 171.42B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
195.96 | 55.88B | 21.39B | 1.59B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
86.48 | 42.55B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
288.28 | 41.48B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
246.22 | 17.25B | 2.90B | 467.20M | 306.90M | 6.37 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-06 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-02-13 | Iniziato | Wells Fargo | Equal Weight |
| 2024-10-15 | Iniziato | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Ripresa | Lake Street | Buy |
| 2024-05-31 | Ripresa | ROTH MKM | Buy |
| 2024-04-26 | Aggiornamento | Stifel | Hold → Buy |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-09-06 | Iniziato | Oppenheimer | Outperform |
| 2023-08-03 | Downgrade | Jefferies | Buy → Hold |
| 2023-05-03 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Iniziato | Jefferies | Buy |
| 2021-02-12 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Aggiornamento | Sidoti | Neutral → Buy |
| 2019-10-24 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Aggiornamento | Lake Street | Hold → Buy |
| 2019-10-14 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Reiterato | Barrington Research | Outperform |
| 2019-07-25 | Aggiornamento | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Aggiornamento | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Ripresa | ROTH Capital | Buy |
| 2018-04-26 | Downgrade | Stifel | Buy → Hold |
| 2018-04-26 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Downgrade | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Iniziato | First Analysis Sec | Overweight |
| 2017-02-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Downgrade | Sidoti | Buy → Neutral |
| 2016-07-28 | Reiterato | Barrington Research | Outperform |
| 2016-02-25 | Reiterato | Barrington Research | Outperform |
Mostra tutto
Lemaitre Vascular Inc Borsa (LMAT) Ultime notizie
Lemaitre Vascular director Roush sells $695k in LMAT stock - Investing.com
LeMaitre Vascular director Ross sells $235k in shares - Investing.com
Barrington Research Has Positive Outlook of LMAT Q3 Earnings - MarketBeat
Roth Capital Forecasts Higher Earnings for LeMaitre Vascular - MarketBeat
Can LeMaitre Vascular (LMAT) Balance Consistent Dividends With Sustained Earnings Growth? - simplywall.st
LMAT Q2 Deep Dive: International Expansion and Product Momentum Drive Upbeat Outlook - ca.finance.yahoo.com
LeMaitre Vascular Inc. Recovery Hinges on Volume BreakoutStock Market Watch With Alerts Shows Unusual Activity - 선데이타임즈
LeMaitre Vascular, Inc. (NASDAQ:LMAT) CEO Sells $9,351,000.00 in Stock - MarketBeat
Can LeMaitre Vascular Inc. outperform in the next rallyUndervalued High Return Candidates - newsyoung.net
Can volume confirm reversal in LeMaitre Vascular Inc.Investment Timeline and ROI Summary Report - Newser
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Townsquare Capital LLC - MarketBeat
Roth Capital Lifts Earnings Estimates for LeMaitre Vascular - MarketBeat
LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
LeMaitre Vascular stock holds Neutral rating at Cantor after strong Q2 - Investing.com Nigeria
LeMaitre Vascular, Inc. to Issue Quarterly Dividend of $0.20 (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Shares Gap Up After Earnings Beat - MarketBeat
Cantor Fitzgerald Issues Positive Forecast for LeMaitre Vascular (NASDAQ:LMAT) Stock Price - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Rating Increased to Outperform at Barrington Research - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Announces Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Issues Q3 2025 Earnings Guidance - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Issues FY 2025 Earnings Guidance - MarketBeat
LeMaitre Vascular Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Lemaitre Vascular Insider Sales: Signal of Caution or Strategic Wealth Management? - AInvest
LeMaitre Vascular To Go Ex-Dividend On August 21st, 2025 With 0.2 USD Dividend Per Share - 富途牛牛
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q2 2025 Earnings Call Transcript - Insider Monkey
LeMaitre Vascular’s Earnings Call Highlights Growth - TipRanks
LeMaitre Vascular Beats Expectations With Strong Sales And Profits - Finimize
Why LeMaitre (LMAT) Stock Is Trading Up Today - TradingView
LeMaitre Vascular Breaks Above 200-Day Moving AverageBullish for LMAT - Nasdaq
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Could Be 25% Above Their Intrinsic Value Estimate - simplywall.st
LEMAITRE VASCULAR INC SEC 10-Q Report - TradingView
LeMaitre (LMAT) Q2 Revenue Jumps 15% - sharewise.com
LeMaitre Vascular Reports Impressive Q2 2025 Financial ResultsNews and Statistics - IndexBox
LeMaitre Vascular Q2 Earnings, Revenue Rise; Raises 2025 Guidance - MarketScreener
LeMaitre raises 2025 revenue guidance to $251M with 15% organic growth as international launches accelerate - MSN
LeMaitre: Q2 Earnings Snapshot - New Haven Register
LeMaitre Vascular Inc (LMAT) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ... - Yahoo Finance
LeMaitre Vascular Inc (LMAT) Q2 2025 Earnings Call Highlights: S - GuruFocus
LeMaitre Vascular Inc (LMAT) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ... By GuruFocus - Investing.com Canada
LeMaitre (LMAT) Q2 Revenue Jumps 15% - The Motley Fool
LeMaitre Vascular's Q2 2025 Earnings Call: Unpacking Key Contradictions in Sales Growth, Pricing Strategies, and Market Opportunities - AInvest
Lemaitre Vascular Inc Azioni (LMAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):